5Definitions

5 Definitions

Note 1: A number of expressions used in this instrument are defined in the Act, including the following:

(a) hospital;
(b) public hospital.

Note 2: Under subsection 4(1A) of the Act, a word or phrase defined for the purposes of the Health Insurance Act 1973 has the meaning that it would have if used in that Act. Expressions used in this instrument that are defined in that Act include the following:

(a) eligible person;
(b) medical practitioner;
(c) private hospital;
(d) specialist.

Note 3: A reference to an approved supplier or an approved hospital authority includes a reference to an HSD hospital authority within the meaning of the National Health (Highly Specialised Drugs Program) Special Arrangement 2021: see section 11 of that instrument.

In this instrument:

Act means the National Health Act 1953.

active ingredient, in relation to a chemotherapy drug, means a drug that is mentioned in the name of the chemotherapy drug.

Note: A chemotherapy drug may be a medicinal preparation containing multiple drugs (see the definition of listed drug in Part VII of the Act).

approved ex‑manufacturer price of a listed brand of a pharmaceutical item has the same meaning as in Part VII of the Act.

approved hospital authority has the same meaning as in Part VII of the Act.

approved medical practitioner has the same meaning as in Part VII of the Act.

approved pharmacist has the same meaning as in Part VII of the Act.

approved supplier has the same meaning as in Part VII of the Act.

authorised prescriber has the meaning given by section 6.

authority prescription means a prescription that has been authorised:

(a) in accordance with section 30 of the Regulations as modified by this instrument; or
(b) in accordance with section 19 of the Listing Instrument as modified by this instrument.

chemotherapy drug means a listed drug that is mentioned in Part 1 of Schedule 1.

Note: Each chemotherapy drug is also mentioned in Part 2 of Schedule 1.